TCBIO
TEXAS CAPITAL BANCSHARES INC/TX
Key Financials
Net Income
$330.2M
↑ 326.1%
Revenue
$1.6M
↑ 977.2%
EPS (Diluted)
$6.79
↑ 430.5%
Total Assets
$31.5B
↑ 2.6%
Shareholders' Equity
$3.6B
↑ 7.8%
Total Liabilities
$27.9B
↑ 2.0%
Cash & Equivalents
$4.4B
↑ 43.7%
Long-term Debt
$620.6M
↓ 6.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 5/18/2026 | View on SEC |
| SCHEDULE 13G | 5/14/2026 | View on SEC |
| SCHEDULE 13G | 4/30/2026 | View on SEC |
| 4 | 4/29/2026 | View on SEC |
| 4 | 4/29/2026 | View on SEC |
| 4 | 4/29/2026 | View on SEC |
| 4 | 4/29/2026 | View on SEC |
| 4 | 4/29/2026 | View on SEC |
| 4 | 4/29/2026 | View on SEC |
| 4 | 4/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TCBIO |
| Company Name | TEXAS CAPITAL BANCSHARES INC/TX |
| CIK | 1077428 |
| Sector | State Commercial Banks |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 6022 |
| SIC Description | State Commercial Banks |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 2149326600 |